Celldex Therapeutics
CLDX
#4748
Rank
HK$15.92 B
Marketcap
HK$239.69
Share price
-0.58%
Change (1 day)
49.47%
Change (1 year)

Market capitalization of Celldex Therapeutics (CLDX)

Market cap: HK$15.92 Billion

As of February 2026 Celldex Therapeutics has a market cap of HK$15.92 Billion. This makes Celldex Therapeutics the world's 4748th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celldex Therapeutics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$15.92 B16.69%
2025HK$13.64 B4.37%
2024HK$13.07 B-22.8%
2023HK$16.93 B3.28%
2022HK$16.40 B16.49%
2021HK$14.07 B161.76%
2020HK$5.37 B1724.83%
2019HK$0.29 B6.04%
2018HK$0.27 B-90.79%
2017HK$3.01 B8.56%
2016HK$2.77 B-76.83%
2015HK$11.99 B-5.43%
2014HK$12.68 B-24.31%
2013HK$16.75 B400.53%
2012HK$3.34 B275.47%
2011HK$0.89 B-13.26%
2010HK$1.02 B-10.42%
2009HK$1.14 B18.72%
2008HK$0.96 B234.12%
2007HK$0.28 B-62.87%
2006HK$0.77 B-27.95%
2005HK$1.08 B-6.64%
2004HK$1.15 B-15.74%
2003HK$1.37 B157.35%
2002HK$0.53 B-71.75%
2001HK$1.89 B-38.31%
2000HK$3.06 B231.92%
1999HK$0.92 B60.17%
1998HK$0.57 B15.21%
1997HK$0.50 B99.96%
1996HK$0.25 B

End of Day market cap according to different sources

On Feb 26th, 2026 the market cap of Celldex Therapeutics was reported to be:

HK$15.92 Billion
by Nasdaq info icon info icon
HK$15.92 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.205 T 7,467.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.599 T 9,943.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$911.55 B 5,623.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
HK$47.97 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
HK$337.59 B 2,019.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.94 B-94.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$4.63 B-70.91%๐Ÿ‡บ๐Ÿ‡ธ USA